RDNT - RadNet Director Trades $275K In Company Stock | Benzinga
It was reported on June 11, that Nayoma Christine Gordon, Director at RadNet (NASDAQ:RDNT) executed a significant insider sell, according to an SEC filing.
What Happened: After conducting a thorough analysis, Gordon sold 4,500 shares of RadNet. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total transaction value is $275,445.
Tracking the Wednesday's morning session, RadNet shares are trading at $61.13, showing a down of 0.0%.
Get to Know RadNet Better
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Financial Milestones: RadNet's Journey
Revenue Growth: RadNet's remarkable performance in 3 months ...